Assessing the full impact of DAPA-HF - Panel discussion and Q&A.
Speaker:
Professor J. McMurray (Glasgow, GB)
Professor S. Solomon (Boston, US)
Doctor C. Ljungman (Goteborg, SE)
Professor S. Verma (Toronto, CA)
Professor R. De Boer (Groningen, NL)
Pharmacological interventions: SGLT2 inhibitors in diabetic heart failure.
28 August 2021
ESC Premium Access
Impact of early initiation of SGLT2 inhibitor on cardiovascular outcomes in diabetic patients with known atherosclerotic cardiovascular disease or risk factors: propensity score matched analysis